News

Deal Announcements

Perosphere Lands Series B Venture Capital

Tuesday, October 27, 2015 5:18:00 AM PDT | VentureDeal
   Danbury, Connecticut  --  Pharmaceutical technology company Perosphere has secured $2.1 million in venture capital financing, according to an SEC regulatory filing.

Perosphere is developing an anticoagulant reversal agent (PER977).

The company recently received Fast Track designation for the PER977 drug drug candidate by the US Food & Drug Administration.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Perosphere is still seeking $9.9 million in additional financing, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1